We are live on ! Find out more
HCWB icon

HCW Biologics
HCWB

18 hedge funds and large institutions have $1.4M invested in HCW Biologics in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

123% more capital invested

Capital invested by funds: $626K → $1.4M (+$770K)

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

13% more funds holding

Funds holding: 16 → 18 (+2)

0.02% more ownership

Funds ownership: 0.01% → 0.03% (+0.02%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 5

Holders
18
Holders Change
+2
Holders Change %
+12.5%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$984K
2
XT
XTX Topco
Cayman Islands
+$16.6K
3
VF
Virtu Financial
New York
+$7.58K
4
Renaissance Technologies
Renaissance Technologies
New York
+$7.35K

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$25K
2
BCM
Bridgeway Capital Management
Texas
-$24.3K
3
Two Sigma Investments
Two Sigma Investments
New York
-$5.13K
4
UBS Group
UBS Group
Switzerland
-$2.6K
5
TRCT
Tower Research Capital (TRC)
New York
-$2.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$903K +$984K +8,432 New
APP
2
Avantax Planning Partners
Iowa
$125K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$81.2K -$700 -6 -0.8%
HighTower Advisors
4
HighTower Advisors
Illinois
$80.7K – – –
CAM
5
Cresset Asset Management
Illinois
$58.9K – – –
PIM
6
Pullen Investment Management
Florida
$33.5K – – –
BlackRock
7
BlackRock
New York
$19.2K -$700 -6 -3%
Vanguard Group
8
Vanguard Group
Pennsylvania
$16.8K – – –
BCM
9
Bridgeway Capital Management
Texas
$15.5K -$24.3K -208 -59%
XT
10
XTX Topco
Cayman Islands
$15.2K +$16.6K +142 New
AWM
11
AE Wealth Management
Kansas
$13.4K – – –
State Street
12
State Street
Massachusetts
$9.57K – – –
VF
13
Virtu Financial
New York
$7K +$7.58K +65 New
Renaissance Technologies
14
Renaissance Technologies
New York
$6.69K +$7.35K +63 New
Two Sigma Investments
15
Two Sigma Investments
New York
$5.39K -$5.13K -44 -47%
Northern Trust
16
Northern Trust
Illinois
$4.55K – – –
TRCT
17
Tower Research Capital (TRC)
New York
$797 -$2.1K -18 -72%
Bank of America
18
Bank of America
North Carolina
$65 – – –
HF
19
HRT Financial
New York
– -$25K -194 Closed
UBS Group
20
UBS Group
Switzerland
– -$2.6K -20 Closed

HCWB Hedge Fund Activity: Q4 2024 in Review

18 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in HCW Biologics (HCWB) for Q4 2024, worth a combined $1.4M — up 123% from $626K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new HCWB positions and 2 closed out — a net gain of 2 holders — while 0 added to existing stakes and 5 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $984K. The largest seller was HRT Financial, exiting entirely with an estimated $25K sold.

  • 18 institutional investors held HCW Biologics (HCWB) as of Q4 2024, up from 16 in Q3 2024.
  • Funds reported $1.4M of HCW Biologics stock for Q4 2024, up 123% quarter-over-quarter.
  • 4 funds opened new HCW Biologics positions in Q4 2024 and 2 closed out, a net change of +2 holders.
  • The largest HCW Biologics buyer in Q4 2024 was Armistice Capital, an estimated $984K added.
  • The largest HCW Biologics seller in Q4 2024 was HRT Financial, an estimated $25K sold.

Based on aggregated 13F filings for Q4 2024.